The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2019 | Treating Patients with PNH and AA
Anita Hill
• 13 Jun 2019
Anita Hill, MBChB (Hons), MRCP, FRCPath, PhD, Leeds Teaching Hospital NHS Trust, Leeds, UK, discusses a paper that investigated patients undergoing both concomitant therapy for their aplastic anemia with immunosuppressive therapy, and eculizumab treatment for paroxysmal nocturnal hemoglobinuria (PNH). This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.
